Cargando…
Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection
Recurrence occurs in approximately 25% of all cases of Clostridium difficile infection (CDI) and poses a unique clinical challenge. Traditionally, treatment options of CDI have been limited to regimes of established antibiotics (eg, pulsed/tapered vancomycin) but faecal transplantation is emerging a...
Autores principales: | Ramsay, Isobel, Brown, Nicholas M, Enoch, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844436/ https://www.ncbi.nlm.nih.gov/pubmed/29535530 http://dx.doi.org/10.1177/1178633718758023 |
Ejemplares similares
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018) -
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
por: Song, Jung Hoon, et al.
Publicado: (2019) -
Updates in Treatment of Recurrent Clostridium difficile Infection
por: Singh, Tanveer, et al.
Publicado: (2019) -
Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence
por: Kumar, Nitin, et al.
Publicado: (2016) -
Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)